NCT01634321View on ClinicalTrials.gov

The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty

PHASE4CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Central Precocious Puberty
Interventions
DRUG

Luphere depot 3.75mg(Leuprolide acetate 3.75mg)

Trial Locations (1)

Unknown

Ajou University medical center, Soo-won

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY